Conferences

The LSX Nordic Congress is the leading partnering, strategy, and investment event serving the Nordic and Baltic region, with qualified 1:1 partnering at its core. The conference gathers senior life science industry decision-makers from the region's most innovative biotech, medtech, and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practices, forge partnerships, and discuss investment – to revolutionise healthcare. Get 15% off registration with the code VVC15

Delegates from Venture Valuation and Biotechgate will attend the event.

The Pharma Partnering Summit specializes in organizing premier Business Development and Licensing Conferences for Senior Executives and Decision-makers in the life sciences industry. These events provide a platform to discover products and partners while exploring potential partnering opportunities that empower the development and commercialization of drugs, as well as advancing the pharma and biotech sectors in general. Get 15% off registration with the code MP-15%

Delegates from Venture Valuation and Biotechgate will attend the event.

UK Biotech Day is an international premier event for life science leaders, innovators, investors and service providers. Our mission is to unite the UK’s vibrant biotech ecosystem, spanning world-class research, dynamic startups, big pharma, and visionary investors, to drive breakthrough partnerships. Join us to discover new opportunities, forge strategic alliances, and help shape the next era of biotech success in the UK and the world. Get 15% off registration with the code MP-15%

Delegates from Venture Valuation and Biotechgate will attend the event.

Building on the success of the inaugural Obesity forums in San Francisco and Leipzig, we are pleased to introduce the 2nd Annual Obesity & Cardiometabolic Innovation Forum (#Sachs_OCIF), taking place at the Royal Sonesta New Orleans, on the 5th of June 2026. The event precedes the American Diabetes Association’s (ADA's) 2026 Scientific Sessions, with virtual meetings scheduled for the 16th - 17th of June. Join global investors, biotech leaders, and clinical innovators at OCIF 2026 – the premier forum where next-generation cardiometabolic science meets market transformation. With the metabolic health sector projected to surpass $250 billion by 2030, OCIF delivers access to the forces reshaping the landscape through scientific breakthroughs, strategic alliances, and headline acquisitions, including Akero, 89 Bio, and Metsera.

RESI San Diego 2026 will take place on June 22 at the JULEP Venue San Diego during the Convention Week, followed by FOUR (4) days of virtual partnering on June 23-24, 29-30. Virtual partnering on the June 29-30 gives you a chance to extend your Convention-week partnering! This hybrid format combines the benefits of in-person networking with the flexibility of online interactions. Get $200 off registration with the code: BTG

Delegates from Venture Valuation and Biotechgate will attend the event.

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe. Whether you work at a public pharmaceutical company, biotech startup, academia, non-profit organization, or government agency; or you work as a researcher, business development professional or investor, BIO is where you'll make valuable connections and build relationships.

Delegates from Venture Valuation and Biotechgate will attend the event.

Now in its fourth year, Asia Bio Partnering Forum will unite over 650 innovators from major Asian markets with global life science leaders to foster dealmaking and collaboration across the region.

Delegates from Venture Valuation and Biotechgate will attend the event.

Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.

Delegates from Venture Valuation and Biotechgate will attend the event.

RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29. This hybrid format combines the benefits of in-person networking with the flexibility of online interactions

Delegates from Venture Valuation and Biotechgate will attend the event.

LSX USA Congress gathers leaders from the US biotech and pharma sectors to network, showcase innovations, and explore partnership opportunities. It offers a unique platform for CEOs, investors, and pharma executives to engage in meaningful discussions and collaborative sessions, shaping the future of healthcare technology.

Delegates from Venture Valuation and Biotechgate will attend the event.

BIOSPAIN is one of the largest biotech events organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and companies participating. 30% of our delegates came from outside of Spain. Also, of the 287 exhibitors, 32% were international. This year, BIOSPAIN will be held in Bilbao, one of the main biotech cluster in Spain and One of Spain’s most avant-garde cities. The event will take place in Pavillion 2, Bilbao Exhibition Cente, located in Barakaldo, less then 20 minutes from downtown Bilbao, it is one of the most modern and largest trade-show complexes in Europe.

Delegates from Venture Valuation and Biotechgate will attend the event.

Returning for its 26th Annual Edition, this established global bio-pharma industry event will address the key challenges and investment trends for 2026, with a strong focus on partnering, alliance management, and future prospects. Leading industry figures will contribute their insights through a series of panel discussions covering the broader market outlook, as well as innovation across different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage, and public companies with leading investors, analysts, money managers, and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners.

Delegates from Venture Valuation and Biotechgate will attend the event.

BioFuture is where relentless therapeutic pioneers, innovators, and investors gather to assess and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions. At this year’s summit, we’ll explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. Be part of the discussions that will shape and transform the future of healthcare.

Delegates from Venture Valuation and Biotechgate will attend the event.

BIO-Europe, Europe's premier biopharma partnering event, is heading to Cologne, Germany on November 9-11, 2026.

Delegates from Venture Valuation and Biotechgate will attend the event.